Patent · US Active

Methods and materials for identifying and treating bet inhibitor-resistant cancers

US11712439B2 · kind B2 · utility

1Cited by
0References
24Claims
0Family size

Assignees

Inventors

Key dates

Filing dateAug 9, 2018
Grant dateAug 1, 2023
Priority date
Expiry dateOct 10, 2038

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/52
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This document provides methods and materials involved in identifying and treating mammals having a cancer resistant to BET inhibitors. For example, methods and materials for administering one or more AKT inhibitors in combination with one or more BET inhibitors to mammals identified as having a cancer resistant to treatment with one or more BET inhibitors in the absence of AKT inhibitors are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.